Your browser doesn't support javascript.
loading
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
Kumar, Anita; Vardhana, Santosha; Moskowitz, Alison J; Porcu, Pierluigi; Dogan, Ahmet; Dubovsky, Jason A; Matasar, Matthew J; Zhang, Zhigang; Younes, Anas; Horwitz, Steven M.
Afiliación
  • Kumar A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Vardhana S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Porcu P; The Comprehensive Cancer Center and The James Cancer Hospital and Solove Research Institute, and.
  • Dogan A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH; and.
  • Dubovsky JA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Matasar MJ; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Zhang Z; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Younes A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY.
Blood Adv ; 2(8): 871-876, 2018 04 24.
Article en En | MEDLINE | ID: mdl-29669753
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Linfoma de Células T Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Linfoma de Células T Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2018 Tipo del documento: Article